Search for: "United States v. Lilly" Results 221 - 240 of 384
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al (Pharmacapsules @ Gowlings)… [read post]
14 Aug 2014, 2:23 pm
Eli Lilly & Co., 744 F.2d 213, 216 (1st Cir. 1984), more appropriate. [read post]
7 Jan 2014, 7:46 am by Charles Kotuby
“Available in the United States,” however, could mean simply that the evidence is obtainable via legal process in the United States; it need not mean that the evidence is physically located in the United States. [read post]
21 Mar 2016, 3:44 am by Amy Howe
  First up is Wittman v. [read post]
10 Mar 2010, 12:30 pm by Lisa McElroy
United States, the Court held on Monday that lawyers could not advise their clients to incur more debt in bad faith, but they could do so in good faith. [read post]
6 Jul 2007, 4:29 am
We've already deplored the recent decision of the West Virginia Supreme Court rejecting the learned intermediary rule outright, State ex rel. [read post]
10 Nov 2010, 1:11 am by Kelly
General Global Fund calls upon drug companies to ‘share without delay’ AIDS drug patents with the Medicines Patent Pool (KEI) Sharing US drug patents with neglected patients: A scientist’s view (IP Watch) Statement of the United States to WTO TRIPS Council on the Paragraph 6 System (KEI) Remarks by UNAIDS Secretariat and on behalf of UNDP: Capacity building on the Paragraph 6 System and related TRIPS flexibilities (KEI) Seed patents and biodiversity (Patent… [read post]
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]
6 Jul 2010, 6:03 pm by Duncan
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]
26 Jun 2017, 1:00 am by Matrix Legal Support Service
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly… [read post]
10 Sep 2018, 1:20 am by Kluwer Patent blogger
’“ 3) International Investment Arbitration, the European Patent Office, and the Future Unified Patent Court by Thomas Musmann “Since the Eli Lilly v. [read post]